Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

Hitoshi Honda; Yasuo Sakurai; Jong Hon Kang; Tadahiro Nakamura; Hirotaka Matsuura; David K. Warren

doi:10.1016/j.ajic.2013.01.018

Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

Hitoshi Honda, Yasuo Sakurai, Jong Hon Kang, Tadahiro Nakamura, Hirotaka Matsuura, David K. Warren

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.

Original language	English
Pages (from-to)	930-932
Number of pages	3
Journal	American Journal of Infection Control
Volume	41
Issue number	10
DOIs	https://doi.org/10.1016/j.ajic.2013.01.018
Publication status	Published - 10-2013
Externally published	Yes

All Science Journal Classification (ASJC) codes

Epidemiology
Health Policy
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ajic.2013.01.018

Cite this

@article{ff692458708043cca64c537d2e50075b,

title = "Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies",

abstract = "The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.",

author = "Hitoshi Honda and Yasuo Sakurai and Kang, \{Jong Hon\} and Tadahiro Nakamura and Hirotaka Matsuura and Warren, \{David K.\}",

note = "Funding Information: Supported by the Society for Healthcare Epidemiology of America (SHEA) International Ambassador Program Award 2012 (to H.H.) and in part by a Prevention Epicenter Program grant from the Centers for Disease Control and Prevention ( CDC1U1C000033301 ; to D.K.W.). ",

year = "2013",

month = oct,

doi = "10.1016/j.ajic.2013.01.018",

language = "English",

volume = "41",

pages = "930--932",

journal = "American Journal of Infection Control",

issn = "0196-6553",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

AU - Honda, Hitoshi

AU - Sakurai, Yasuo

AU - Kang, Jong Hon

AU - Nakamura, Tadahiro

AU - Matsuura, Hirotaka

AU - Warren, David K.

N1 - Funding Information: Supported by the Society for Healthcare Epidemiology of America (SHEA) International Ambassador Program Award 2012 (to H.H.) and in part by a Prevention Epicenter Program grant from the Centers for Disease Control and Prevention ( CDC1U1C000033301 ; to D.K.W.).

PY - 2013/10

Y1 - 2013/10

N2 - The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.

AB - The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.

UR - https://www.scopus.com/pages/publications/84884901807

UR - https://www.scopus.com/inward/citedby.url?scp=84884901807&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2013.01.018

DO - 10.1016/j.ajic.2013.01.018

M3 - Article

C2 - 23594477

AN - SCOPUS:84884901807

SN - 0196-6553

VL - 41

SP - 930

EP - 932

JO - American Journal of Infection Control

JF - American Journal of Infection Control

IS - 10

ER -

Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this